Upstream Bio (UPB) Preferred Dividend Payments (2023 - 2024)
Upstream Bio (UPB) recorded quarterly Preferred Dividend Payments of $548000.0 in Q4 2024, down 89.13% quarter-over-quarter from $5.0 million in Q3 2024, and down 82.61% on a YoY basis from $3.2 million in Q1 2024.
Upstream Bio (UPB) Preferred Dividend Payments (2023 - 2024) Analysis & Trends
Upstream Bio's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $548000.0 for Q4 2024.
- In Q4 2024, Preferred Dividend Payments fell 82.61% year-over-year to $548000.0; the TTM figure through Dec 2025 stood at $548000.0 (down 95.97% YoY), while the FY2024 annual figure was $13.6 million, down 23.3% from the prior year.
- Preferred Dividend Payments was $548000.0 for Q4 2024 at Upstream Bio, down from $5.0 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $5.0 million in Q3 2024 to a low of $548000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Upstream Bio | 339.03 Mn | 339.03 Mn | -3.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 548,000.00 |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | 4.88 Mn |
| Mar 31, 2024 | 3.12 Mn |
| Dec 31, 2023 | 3.15 Mn |
| Sep 30, 2023 | 3.15 Mn |